Press Releases

Date	Title and Summary	Additional Formats
January 3, 2024	Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024	View HTML PDF Version
November 8, 2023	Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance	View HTML PDF Version
November 7, 2023	Vericel to Present at the Stephens Annual Investment Conference	View HTML PDF Version
October 25, 2023	Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023	View HTML PDF Version
September 28, 2023	Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid	View HTML PDF Version
September 20, 2023	Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults	View HTML PDF Version
September 6, 2023	Vericel to Present at the Morgan Stanley Global Healthcare Conference	View HTML PDF Version
August 2, 2023	Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance	View HTML PDF Version
July 20, 2023	Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023	View HTML PDF Version
May 10, 2023	Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance	View HTML PDF Version

Investor Relations